By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NovoCure Ltd. 

Bridgeport  Connecticut  06610  U.S.A.
Phone: n/a Fax:


Medical Device

Company News
NovoCure To Report First Quarter 2017 Financial Results 3/28/2017 6:42:45 AM
NovoCure Receives MHLW Approval For Second Generation Optune In Japan 3/20/2017 6:05:20 AM
NovoCure Announces Data Presentations At The AACR Annual Meeting 2017 3/2/2017 7:10:12 AM
NovoCure Announces Departure Of Chief Commercial Officer 2/23/2017 7:49:29 AM
NovoCure Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Company Update 2/23/2017 6:38:36 AM
First Patient Enrolled In NovoCure’s Phase III Pivotal LUNAR Trial Testing Tumor Treating Fields For The Treatment Of Advanced Non-Small Cell Lung Cancer After Failing Platinum-Based Therapy 2/15/2017 6:26:02 AM
NovoCure Release: Company’s Optune Now Available At 500 Cancer Treatment Centers In The U.S. 1/19/2017 8:58:37 AM
NovoCure Release: Company To Report Fourth Quarter And Full Year 2016 Financial Results 1/10/2017 11:45:26 AM
NovoCure Rlease: Pharma Announces Preliminary Fourth Quarter And Full Year 2016 Operating Statistics 1/10/2017 11:42:22 AM
NovoCure’s Optune (NovoTTF-100A) Approved In Japan For The Treatment Of Newly Diagnosed Glioblastoma 12/19/2016 9:54:52 AM